Institutional Fund
Elmind Capital, LP
New York, NYCIK 20522132 filings on record
Portfolio Value
$352.22M
Q1 2026
Holdings
34
Reported positions
New Buys
2
Opened this quarter
QoQ Change
+3.9%
from $338.85M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Cogent Biosciences Inc12.8%
- Syndax Pharmaceuticals Inc12.3%
- Celldex Therapeutics Inc New7.8%
- Cytomx Therapeutics Inc6.1%
- Kalvista Pharmaceuticals Inc5.8%
- Cg Oncology Inc5.6%
- Other49.6%
Portfolio Holdings
34 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Cogent Biosciences Inc | 1.17M | $45.06M | 12.8% | 0 | Held |
| 2 | Syndax Pharmaceuticals Inc | 1.85M | $43.33M | 12.3% | 0 | Held |
| 3 | Celldex Therapeutics Inc New | 865.0K | $27.44M | 7.8% | 0 | Held |
| 4 | Cytomx Therapeutics Inc | 4.55M | $21.39M | 6.1% | +3.85M | Added |
| 5 | Kalvista Pharmaceuticals Inc | 1.02M | $20.56M | 5.8% | +220.0K | Added |
| 6 | Cg Oncology Inc | 291.8K | $19.75M | 5.6% | −200.7K | Reduced |
| 7 | Vera Therapeutics Inc | 482.5K | $19.41M | 5.5% | 0 | Held |
| 8 | Vaxcyte Inc | 316.5K | $18.39M | 5.2% | +25.0K | Added |
| 9 | Pharvaris N V | 475.8K | $13.44M | 3.8% | 0 | Held |
| 10 | Tyra Biosciences Inc | 350.0K | $13.40M | 3.8% | 0 | Held |
24 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio